Expression of steroid hormone receptors, their regulated proteins, and bcl-2 protein in myofibroblastoma of the breast

Histopathology

Volumn 36, Issue 6, 2000, Pages 515-521

  Magro, G ^a   Bisceglia, M ^b   Michal, M ^c  

^a UNIVERSITY OF CATANIA   (Italy)

^b CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^c CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Bcl 2 protein; Breast; Myofibroblastoma; Steroid hormone receptors

Indexed keywords

ANDROGEN RECEPTOR; ESTROGEN RECEPTOR; PARAFFIN; PROGESTERONE RECEPTOR; PROSTATE SPECIFIC ANTIGEN; PROTEIN BCL 2; PROTEIN PS2; STEROID HORMONE; STEROID RECEPTOR;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; BREAST HAMARTOMA; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; FEMALE; GRANULAR CELL TUMOR; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MYOFIBROBLAST; PATHOGENESIS; PRIORITY JOURNAL; PROTO ONCOGENE; PSEUDOTUMOR; SPINDLE CELL CARCINOMA; TISSUE SECTION;

ACTINS; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD34; BREAST; BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; DESMIN; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MUSCLE, SMOOTH; NEOPLASMS, MUSCLE TISSUE; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, ANDROGEN; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RECEPTORS, STEROID;

EID: 0034038979     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2559.2000.00907.x     Document Type: Article

References (36)

1. 1. Toker C, Tang CK, Whitely JF, Berkheiser SW, Rachman R. Benign spindle cell breast tumor. Cancer 1981: 48; 1615-1622.
2. 2. Boger A. Benign spindle cell tumor of the male breast. Pathol. Res. Pract. 1984: 178; 395-398.
3. 3. Magro G, Bisceglia M, Pasquinelli G. Benign spindle cell tumor of the breast with prominent adipocytic component. Ann. Diagn. Pathol. 1998: 2; 306-311.
4. 4. Chan KW, Ghadially FN, Alagaratnam TT. Benign spindle cell tumour of breast - a variant of spindle cell lipoma or fibroma of breast? Pathology 1984: 16; 331-337.
5. 5. Begin LR. Myogenic stromal tumor of the male breast (so-called myofibroblastoma). Ultrastruct. Pathol. 1991: 15; 613-622.
6. 6. Lew WYC. Spindle cell lipoma of the breast: a case report and literature review. Diagn. Cytopathol. 1993: 9; 434-437.
7. 7. Smith DN, Denison CM, Lester SC. Spindle cell lipoma of the breast. A case report. Acta Radiol. 1996: 37; 893-895.
8. 8. Damiani S, Miettinen M, Peterse JL, Eusebi V. Solitary fibrous tumor (myofibroblastoma) of the breast. Virchows Arch. A 1994: 425; 89-92.
9. 9. Khalifa MA, Montgomery EA, Azumi N, Zeman RK, Min KW, Lack EE. Solitary fibrous tumors: a series of lesions, some in unusual sites. South. Med. J. 1994: 90; 793-799.
10. 10. Salomao DR, Crotty TB, Nascimento AG. Myofibroblastoma and solitary fibrous tumors of the breast: histopathological and immunohistochemical comparative study (abstract). Mod. Pathol. 1997: 10; 25A.
11. 11. Wargotz ES, Weiss SW, Norris HJ. Myofibroblastoma of the breast. Sixteen cases of a distinctive benign mesenchymal tumor. Am. J. Surd. Pathol. 1987: 11; 493-502.
12. 12. Morgan MB, Pitha JV. Myofibroblastoma of the breast revisited: an aetiologic association with androgens? Hum. Pathol. 1998: 29; 347-351.
13. 13. Gocht A, Bosmuller HC, Bassler R et al. Breast tumors with myofibroblastic differentiation: clinico-pathological observations in myofibroblastoma and myofibrosarcoma. Pathol Res. Pract. 1999: 195; 1-10.
14. 14. Silverman JS, Hamilton J, Tmasen A. Myofibroblastoma of the breast revisited: an aetiologic association with androgens? Hum. Pathol. 1999: 30; 359-360.
15. 15. Rosen PP, ed. Benign Mesenchymal Neoplasms. In Rosen's Breast Pathology. Philadelphia: Lippincot-Raven, 1997: 665-672.
16. 16. Hockenberry D, Nunez G, Milliman C, Schreiber RD, Korsmeier SJ. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 1990: 348; 334-336.
17. 17. Bhargava V, Kell DL, van de Rijn M, Warnke RA. Bcl-2 immunoreactivity in breast carcinoma correlates with hormone receptor positivity. Am. J. Clin. Pathol. 1994: 145; 535-540.
18. 18. Doglioni C, Dei Tos A, Laurina L. The prevalence of bcl-2 immunoreactivity in breast carcinomas and its clinico-pathological correlates with particular reference to oestrogen receptor status. Virchows Arch. 1994: 424: 47-51.
19. 19. Binder C, Marx D, Overhoff R, Binder L, Schauer A, Hiddemann W. Bcl-2 protein expression in breast cancer in relation to established prognostic factors and other clinico-pathological variables. Ann. Oncol 1995: 6; 1005-1010.
20. 20. Barbareschi M, Caffo O, Veronese S, Leek RD, Fina P, Fox S et al. Bcl-2 and p53 expression in node-negative breast carcinoma. A study with long-term follow-up. Hum. Pathol. 1996: 27; 1149-1155.
21. 21. Suster S, Fisher C, Moran CA. Expression of bcl-2 oncoprotein in benign and malignant spindle cell tumors of soft tissue, skin, serosal surfaces, and gastrointestinal tract. Am. J. Surg. Pathol. 1998: 22; 863-872.
22. 22. Miettinen M, Sarlomo-Rikala M, Kovatich AJ. Cell-type-and tumour-type-related patterns of bcl-2 reactivity in mesenchymal cells and soft tissue tumours. Virchows Arch. 1998: 433; 255-260.
23. 23. Negri S, Bonzanini M, Togni R, Castelli P, Dalla Palma P, Fiaccavento S. Fine needle aspiration of myofibroblastoma of the breast. Case report. Pathologica 1995: 87; 719-722.
24. 24. Magro G, Fraggetta F, Torrisi A, Emmanuele C, Lanzafame S. Myofibroblastoma of the breast with hemangiopericytoma-like pattern and pleomorphic lipoma-like areas: report of a case with diagnostic and histogenetic considerations. Pathol. Res. Pract. 1999: 195; 257-262.
25. 25. Bisceglia M, Fusilli S, Zaffarano L, Firentino F, Tardio B. Inflammatory pseudotumor of the breast. Case report and literature review. Pathologica 1995: 87; 59-64.
26. 26. Magro G, Mesiti M. Breast and pectoralis musculo-aponeurotic fibromatosis: two independent lesions occurring in the same patient. A case report. Pathol. Res. Pract. 1998: 194; 867-871.
27. 27. Magro G, Bisceglia M. Muscular hamartoma of the breast. Case report and review of the literature. Pathol. Res. Pract. 1998: 194; 349-355.
28. 28. Shi SR, Chaiwun B, Young L, Cote RJ, Taylor CR. Antigen retrieval technology utilizing citrate buffer in immunohistochemical demonstration of the androgen receptor in formalin fixed paraffin sections. J. Histochem. Cytochem. 1993: 41; 1599-1604.
29. 29. Anderson C, Ricci A, Pedersen CA. Immunocytochemical analysis of estrogen and progesterone receptors in benign stromal lesions of the breast. Evidence for hormonal etiology in pseudoangiomatous hyperplasia of mammary stroma. Am. J. Surg. Pathol. 1991: 15; 145-149.
30. 30. Powell CM, Cranor ML, Rosen PP. Pseudoangiomatous stromal hyperplasia (PASH). A mammary stromal tumor with myofibroblastic differentiation. Am. J. Surg. Pathol. 1995: 19; 270-277.
31. 31. Milanezi MFG, Saggioro FP, Zanati SG, Bazan R, Schmitt FC. Pseudoangiomatous hyperplasia of mammary stroma associated with gynaecomastia. J. Clin. Pathol. 1998: 51; 204-206.
32. 32. Sasano H, Kimura M, Shizawa S, Kimura N, Nagura H. Aromatase and steroid receptors in gynecomastia and male breast carcinoma: an immunohistochemical study. J. Clin. Endocrinol. Metab 1996: 81; 3063-3067.
33. 33. Rayson D, Erlichman C, Suman VJ, Roche PC, Wold CE, Ingle JN et al. Molecular markers in male breast carcinoma. Cancer 1998: 83; 1947-55.
34. 34. Luqmani YA, Campbell T, Soomro S, Shousha S, Rio MC, Coombes RC. Immunohistochemical localisation of pS2 protein in ductal carcinoma in situ and benign lesions of the breast. Br. J. Cancer 1993: 67; 749-753.
35. 35. Umekita Y, Yoshida H. Immunohistochemical study of hormone receptor and hormone-regulated protein expression in phyllodes tumour: comparison with fibroadenoma. Virchows Arch. 1998: 433; 311-314.
36. 36. Chan JKC. Solitary fibrous tumor - everywhere, and a diagnosis in vogue. Histopathology 1997: 31; 568-576.